Approval · Notice of Compliance 37394 · 2026
PEGASYS: Notice of Compliance 37394
Issued April 20, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37394
- Date
- April 20, 2026
- Company
- Pharmaand Gmbh1020 Vienna, --, Austria
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in drug substance manufacturer and associated quality updates
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PEGASYS | Not yet assigned | — |
Medicinal ingredients
- PEGINTERFERON ALFA-2A 180 MCG per 0.5ML